Cited by 93Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial

Open access
Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William, for the VADT Study Group·2011·Diabetes Care

Abstract

OBJECTIVE: Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS: Participants in the VADT (n = 1,791) with hypertension received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups. Blood pressure levels of all subjects at baseline and On-Study were analyzed to detect associations with CVD risk. The primary outcome was the time from randomization to the first occurrence of myocardial infarction, stroke, congestive heart failure, surgery for vascular disease, inoperable coronary disease, amputation for ischemic gangrene, or CVD death. RESULTS: Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P < 0.001) and On-Study (HR 1.469, P = 0.002). DBP <70 mmHg increased CVD events at baseline (HR 1.482, P < 0.001) and On-Study (HR 1.491, P < 0.001). Combined blood pressure categories indicated high risk for CVD events for SBP ≥140 with DBP <70 mmHg at baseline (HR 1.785, P = 0.03) and On-Study (HR 2.042, P = 0.003) and nearly all SBP with DBP <70 mmHg. CONCLUSIONS: Increased risk of CVD events with SBP ≥140 mmHg emphasizes the urgency for treatment of systolic hypertension. Increased risk with DBP <70 mmHg, even when combined with SBP in guideline-recommended target ranges, supports a new finding in patients with type 2 diabetes. The results emphasize that DBP <70 mmHg in these patients was associated with elevated CVD risk and may best be avoided.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc10-1420

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A post-hoc analysis of the cohort of participants with diabetes in the INVEST trial, whose mean age was about 65 years, showed that achieved SBP under 130 mmHg was not associated with improved cardiovascular outcomes compared with SBP under 140 mmHg.

    “A post-hoc analysis of the cohort of participants with diabetes in the INVEST trial, whose mean age was about 65 years, showed that achieved SBP under 130 mmHg was not associated with improved cardiovascular outcomes compared with SBP under 140 mmHg47.”

    From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [47]

  • A post-hoc analysis of the VADT trial showed that those whose SBP was ≥140 mm Hg had increased mortality, while those at <105 mm Hg, 105-129 mm Hg, and 130-139 mm Hg had equally low mortality rates; for diastolic BP, achieved values <70 mm Hg were associated with higher mortality, while those of 70-79 mm Hg or >80 mm Hg were equally low.

    “A post-hoc analysis of the VADT trial (in which the goal BP was < 130/80 mm Hg) showed, similarly, that those whose SBP was ≥ 140 mm Hg had increased mortality, while those at < 105 mm Hg, 105–129 mm Hg, and 130–139 mm Hg had equally low mortality rates. For diastolic BP, achieved values < 70 mm Hg were associated with higher mortality, while those of 70–79 mm Hg or > 80 mm Hg were equally low48.”

    From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [48]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 23 · Cited by 93

Authors
Anderson, R. J., Bahn, G. D., Moritz, T. E., Kaufman, D., Abraira, C., Duckworth, W., & for the VADT Study Group
Affiliations
  • Omaha VA Medical Center (US)
  • Edward Hines, Jr. VA Hospital (US)
  • Miami VA Healthcare System (US)
  • Phoenix VA Health Care System (US)
Corresponding author
Anderson, Robert J.
Venue
Diabetes Care
Published
2010-11-08
Volume
34
Issue
1
Pages
34-38
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2149674228
Cited by
93
References
23
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 15 · 2014: 6 · 2013: 10 · 2012: 13
FWCI
6.80
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • U.S. Department of Veterans Affairs
  • GlaxoSmithKline
  • Sanofi
  • Office of Research and Development
  • Novo Nordisk
  • National Institutes of Health
  • National Eye Institute
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
blood pressure, cardiovascular risk, type 2 diabetes, systolic blood pressure, diastolic blood pressure, hypertension, cardiovascular events, tight glycemic control, myocardial infarction, stroke, congestive heart failure
MeSH terms
Aged, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review